190 related articles for article (PubMed ID: 30829478)
1. Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim.
Su L; Wang Y; Wang J; Mifune Y; Morin MD; Jones BT; Moresco EMY; Boger DL; Beutler B; Zhang H
J Med Chem; 2019 Mar; 62(6):2938-2949. PubMed ID: 30829478
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide.
Jin MS; Kim SE; Heo JY; Lee ME; Kim HM; Paik SG; Lee H; Lee JO
Cell; 2007 Sep; 130(6):1071-82. PubMed ID: 17889651
[TBL] [Abstract][Full Text] [Related]
3. Next-Generation Diprovocims with Potent Human and Murine TLR1/TLR2 Agonist Activity That Activate the Innate and Adaptive Immune Response.
Yang MH; Russell JL; Mifune Y; Wang Y; Shi H; Moresco EMY; Siegwart DJ; Beutler B; Boger DL
J Med Chem; 2022 Jul; 65(13):9230-9252. PubMed ID: 35767437
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant effect of the novel TLR1/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice.
Wang Y; Su L; Morin MD; Jones BT; Mifune Y; Shi H; Wang KW; Zhan X; Liu A; Wang J; Li X; Tang M; Ludwig S; Hildebrand S; Zhou K; Siegwart DJ; Moresco EMY; Zhang H; Boger DL; Beutler B
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8698-E8706. PubMed ID: 30150374
[TBL] [Abstract][Full Text] [Related]
5. Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists.
Morin MD; Wang Y; Jones BT; Mifune Y; Su L; Shi H; Moresco EMY; Zhang H; Beutler B; Boger DL
J Am Chem Soc; 2018 Oct; 140(43):14440-14454. PubMed ID: 30272974
[TBL] [Abstract][Full Text] [Related]
6. Identification and immunological evaluation of novel TLR2 agonists through structural optimization of Diprovocim.
Wang X; Wang Y; Zhu Y; Lei X; Zhang M; Li Y
Eur J Med Chem; 2022 Dec; 243():114771. PubMed ID: 36174413
[TBL] [Abstract][Full Text] [Related]
7. Mapping of a microbial protein domain involved in binding and activation of the TLR2/TLR1 heterodimer.
Liang S; Hosur KB; Lu S; Nawar HF; Weber BR; Tapping RI; Connell TD; Hajishengallis G
J Immunol; 2009 Mar; 182(5):2978-85. PubMed ID: 19234193
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between 4-1BB and TLR1-TLR2 Signaling in CD8+ T Cells Regulates TLR2's Costimulatory Effects.
Joseph AM; Srivastava R; Zabaleta J; Davila E
Cancer Immunol Res; 2016 Aug; 4(8):708-16. PubMed ID: 27267778
[TBL] [Abstract][Full Text] [Related]
9. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling.
Farhat K; Riekenberg S; Heine H; Debarry J; Lang R; Mages J; Buwitt-Beckmann U; Röschmann K; Jung G; Wiesmüller KH; Ulmer AJ
J Leukoc Biol; 2008 Mar; 83(3):692-701. PubMed ID: 18056480
[TBL] [Abstract][Full Text] [Related]
10. Sperm activate TLR2/TLR1 heterodimerization to induce a weak proinflammatory response in the bovine uterus.
Mansouri A; Yousef MS; Kowsar R; Usui N; Akthar I; Miyamoto A
Front Immunol; 2023; 14():1158090. PubMed ID: 37180107
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling.
Massari P; Visintin A; Gunawardana J; Halmen KA; King CA; Golenbock DT; Wetzler LM
J Immunol; 2006 Feb; 176(4):2373-80. PubMed ID: 16455995
[TBL] [Abstract][Full Text] [Related]
12. Two modes of ligand recognition by TLRs.
Brodsky I; Medzhitov R
Cell; 2007 Sep; 130(6):979-81. PubMed ID: 17889640
[TBL] [Abstract][Full Text] [Related]
13. Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex.
Ranoa DRE; Kelley SL; Tapping RI
J Biol Chem; 2013 Apr; 288(14):9729-9741. PubMed ID: 23430250
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis for recognition of bacterial ligands at equine TLR2, TLR1 and TLR6.
Irvine KL; Hopkins LJ; Gangloff M; Bryant CE
Vet Res; 2013 Jul; 44(1):50. PubMed ID: 23826682
[TBL] [Abstract][Full Text] [Related]
15. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex.
Nakata T; Yasuda M; Fujita M; Kataoka H; Kiura K; Sano H; Shibata K
Cell Microbiol; 2006 Dec; 8(12):1899-909. PubMed ID: 16848791
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling.
Gautam JK; Ashish ; Comeau LD; Krueger JK; Smith MF
J Biol Chem; 2006 Oct; 281(40):30132-42. PubMed ID: 16893894
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.
Shukla S; Richardson ET; Drage MG; Boom WH; Harding CV
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30037791
[No Abstract] [Full Text] [Related]
18. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.
Kang JY; Nan X; Jin MS; Youn SJ; Ryu YH; Mah S; Han SH; Lee H; Paik SG; Lee JO
Immunity; 2009 Dec; 31(6):873-84. PubMed ID: 19931471
[TBL] [Abstract][Full Text] [Related]
19. Volatile Anesthetic Sevoflurane Attenuates Toll-Like Receptor 1/2 Activation.
Mitsui Y; Hou L; Huang X; Odegard KC; Pereira LM; Yuki K
Anesth Analg; 2020 Aug; 131(2):631-639. PubMed ID: 32149756
[TBL] [Abstract][Full Text] [Related]
20. Differential adapter recruitment by TLR2 co-receptors.
Piao W; Ru LW; Toshchakov VY
Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27150837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
